Global Antibacterial Active Peptide Market Research Report 2023

Antibacterial Active Peptide Market

Antimicrobial peptides, also known as host defense peptides, are a class of basic polypeptide substances with antibacterial activities related to innate immunity. Antimicrobial peptides have antifungal, antitumor, and antiviral activities, and have the advantages of good thermal stability and specificity. They have good application prospects in the fields of medicine, health care products, agricultural product preservation, feed, and breeding.

Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Antibacterial Active Peptide market research.

Antimicrobial peptides can rapidly kill many microorganisms, including bacteria, fungi, viruses and tumor cells, especially those pathogens that are resistant to multiple antibiotics. Unlike antibiotics that inhibit or kill microorganisms, antimicrobial peptides can kill or inhibit pathogens through a variety of mechanisms, including acting on pathogen cell membranes, maintaining the body's intestinal health, enhancing the body's immunity, and regulating host inflammatory responses. Antimicrobial peptides are widely used in the market. In agriculture, they can be used as feed additives and are suitable for raising various animals. In medicine, they can be used as excellent substitutes for antibiotics, and are also considered to be promising drugs that can overcome cancer and AIDS in the future; In industry, it can be used as a green preservative; in human life, it can be used as a substitute for health care products and antibacterial substances. With the continuous improvement of the economy and living standards, people will pay more and more attention to their own health, and the demand for antimicrobial peptides will continue to increase.

Report Scope

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Antibacterial Active Peptide market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.

Scope of Antibacterial Active Peptide Market Report

1.1 Product Definition

1.2 Antibacterial Active Peptide Segment by Type

1.2.1 Global Antibacterial Active Peptide Market Value Growth Rate Analysis by Type 2022 VS 2029

1.2.2 Microbial Antimicrobial Peptides

1.2.3 Plant Antimicrobial Peptides

1.2.4 Animal Antimicrobial Peptides

1.2.5 Others

1.3 Antibacterial Active Peptide Segment by Application

1.3.1 Global Antibacterial Active Peptide Market Value Growth Rate Analysis by Application: 2022 VS 2029

1.3.2 Food

1.3.3 Medical

1.3.4 Animal Food

1.3.5 Others

1.4 Global Market Growth Prospects

1.4.1 Global Antibacterial Active Peptide Production Value Estimates and Forecasts (2018-2029)

1.4.2 Global Antibacterial Active Peptide Production Capacity Estimates and Forecasts (2018-2029)

1.4.3 Global Antibacterial Active Peptide Production Estimates and Forecasts (2018-2029)

1.4.4 Global Antibacterial Active Peptide Market Average Price Estimates and Forecasts (2018-2029)

1.5 Assumptions and Limitations

2.1 Global Antibacterial Active Peptide Production Market Share by Manufacturers (2018-2023)

2.2 Global Antibacterial Active Peptide Production Value Market Share by Manufacturers (2018-2023)

2.3 Global Key Players of Antibacterial Active Peptide, Industry Ranking, 2021 VS 2022 VS 2023

2.4 Global Antibacterial Active Peptide Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.5 Global Antibacterial Active Peptide Average Price by Manufacturers (2018-2023)

2.6 Global Key Manufacturers of Antibacterial Active Peptide, Manufacturing Base Distribution and Headquarters

2.7 Global Key Manufacturers of Antibacterial Active Peptide, Product Offered and Application

2.8 Global Key Manufacturers of Antibacterial Active Peptide, Date of Enter into This Industry

2.9 Antibacterial Active Peptide Market Competitive Situation and Trends

2.9.1 Antibacterial Active Peptide Market Concentration Rate

2.9.2 Global 5 and 10 Largest Antibacterial Active Peptide Players Market Share by Revenue

2.10 Mergers & Acquisitions, Expansion

3.1 Global Antibacterial Active Peptide Production Value Estimates and Forecasts by Region: 2018 VS 2022 VS 2029

3.2 Global Antibacterial Active Peptide Production Value by Region (2018-2029)

3.2.1 Global Antibacterial Active Peptide Production Value Market Share by Region (2018-2023)

3.2.2 Global Forecasted Production Value of Antibacterial Active Peptide by Region (2024-2029)

3.3 Global Antibacterial Active Peptide Production Estimates and Forecasts by Region: 2018 VS 2022 VS 2029

3.4 Global Antibacterial Active Peptide Production by Region (2018-2029)

3.4.1 Global Antibacterial Active Peptide Production Market Share by Region (2018-2023)

3.4.2 Global Forecasted Production of Antibacterial Active Peptide by Region (2024-2029)

3.5 Global Antibacterial Active Peptide Market Price Analysis by Region (2018-2023)

3.6 Global Antibacterial Active Peptide Production and Value, Year-over-Year Growth

3.6.1 North America Antibacterial Active Peptide Production Value Estimates and Forecasts (2018-2029)

3.6.2 Europe Antibacterial Active Peptide Production Value Estimates and Forecasts (2018-2029)

3.6.3 China Antibacterial Active Peptide Production Value Estimates and Forecasts (2018-2029)

3.6.4 Japan Antibacterial Active Peptide Production Value Estimates and Forecasts (2018-2029)

4.1 Global Antibacterial Active Peptide Consumption Estimates and Forecasts by Region: 2018 VS 2022 VS 2029

4.2 Global Antibacterial Active Peptide Consumption by Region (2018-2029)

4.2.1 Global Antibacterial Active Peptide Consumption by Region (2018-2023)

4.2.2 Global Antibacterial Active Peptide Forecasted Consumption by Region (2024-2029)

4.3 North America

4.3.1 North America Antibacterial Active Peptide Consumption Growth Rate by Country: 2018 VS 2022 VS 2029

4.3.2 North America Antibacterial Active Peptide Consumption by Country (2018-2029)

4.3.3 United States

4.3.4 Canada

4.4 Europe

4.4.1 Europe Antibacterial Active Peptide Consumption Growth Rate by Country: 2018 VS 2022 VS 2029

4.4.2 Europe Antibacterial Active Peptide Consumption by Country (2018-2029)

4.4.3 Germany

4.4.4 France

4.4.5 U.K.

4.4.6 Italy

4.4.7 Russia

4.5 Asia Pacific

4.5.1 Asia Pacific Antibacterial Active Peptide Consumption Growth Rate by Region: 2018 VS 2022 VS 2029

4.5.2 Asia Pacific Antibacterial Active Peptide Consumption by Region (2018-2029)

4.5.3 China

4.5.4 Japan

4.5.5 South Korea

4.5.6 China Taiwan

4.5.7 Southeast Asia

4.5.8 India

4.6 Latin America, Middle East & Africa

4.6.1 Latin America, Middle East & Africa Antibacterial Active Peptide Consumption Growth Rate by Country: 2018 VS 2022 VS 2029

4.6.2 Latin America, Middle East & Africa Antibacterial Active Peptide Consumption by Country (2018-2029)

4.6.3 Mexico

4.6.4 Brazil

4.6.5 Turkey

5.1 Global Antibacterial Active Peptide Production by Type (2018-2029)

5.1.1 Global Antibacterial Active Peptide Production by Type (2018-2023)

5.1.2 Global Antibacterial Active Peptide Production by Type (2024-2029)

5.1.3 Global Antibacterial Active Peptide Production Market Share by Type (2018-2029)

5.2 Global Antibacterial Active Peptide Production Value by Type (2018-2029)

5.2.1 Global Antibacterial Active Peptide Production Value by Type (2018-2023)

5.2.2 Global Antibacterial Active Peptide Production Value by Type (2024-2029)

5.2.3 Global Antibacterial Active Peptide Production Value Market Share by Type (2018-2029)

5.3 Global Antibacterial Active Peptide Price by Type (2018-2029)

6.1 Global Antibacterial Active Peptide Production by Application (2018-2029)

6.1.1 Global Antibacterial Active Peptide Production by Application (2018-2023)

6.1.2 Global Antibacterial Active Peptide Production by Application (2024-2029)

6.1.3 Global Antibacterial Active Peptide Production Market Share by Application (2018-2029)

6.2 Global Antibacterial Active Peptide Production Value by Application (2018-2029)

6.2.1 Global Antibacterial Active Peptide Production Value by Application (2018-2023)

6.2.2 Global Antibacterial Active Peptide Production Value by Application (2024-2029)

6.2.3 Global Antibacterial Active Peptide Production Value Market Share by Application (2018-2029)

6.3 Global Antibacterial Active Peptide Price by Application (2018-2029)

7.1 Lytix Biopharma AS

7.1.1 Lytix Biopharma AS Antibacterial Active Peptide Corporation Information

7.1.2 Lytix Biopharma AS Antibacterial Active Peptide Product Portfolio

7.1.3 Lytix Biopharma AS Antibacterial Active Peptide Production, Value, Price and Gross Margin (2018-2023)

7.1.4 Lytix Biopharma AS Main Business and Markets Served

7.1.5 Lytix Biopharma AS Recent Developments/Updates

7.2 Genscript

7.2.1 Genscript Antibacterial Active Peptide Corporation Information

7.2.2 Genscript Antibacterial Active Peptide Product Portfolio

7.2.3 Genscript Antibacterial Active Peptide Production, Value, Price and Gross Margin (2018-2023)

7.2.4 Genscript Main Business and Markets Served

7.2.5 Genscript Recent Developments/Updates

7.3 Biosynth Carbosynth

7.3.1 Biosynth Carbosynth Antibacterial Active Peptide Corporation Information

7.3.2 Biosynth Carbosynth Antibacterial Active Peptide Product Portfolio

7.3.3 Biosynth Carbosynth Antibacterial Active Peptide Production, Value, Price and Gross Margin (2018-2023)

7.3.4 Biosynth Carbosynth Main Business and Markets Served

7.3.5 Biosynth Carbosynth Recent Developments/Updates

7.4 CPC Scientific

7.4.1 CPC Scientific Antibacterial Active Peptide Corporation Information

7.4.2 CPC Scientific Antibacterial Active Peptide Product Portfolio

7.4.3 CPC Scientific Antibacterial Active Peptide Production, Value, Price and Gross Margin (2018-2023)

7.4.4 CPC Scientific Main Business and Markets Served

7.4.5 CPC Scientific Recent Developments/Updates

7.5 Peptilogics, Inc.

7.5.1 Peptilogics, Inc. Antibacterial Active Peptide Corporation Information

7.5.2 Peptilogics, Inc. Antibacterial Active Peptide Product Portfolio

7.5.3 Peptilogics, Inc. Antibacterial Active Peptide Production, Value, Price and Gross Margin (2018-2023)

7.5.4 Peptilogics, Inc. Main Business and Markets Served

7.5.5 Peptilogics, Inc. Recent Developments/Updates

7.6 MaxWell Biosciences

7.6.1 MaxWell Biosciences Antibacterial Active Peptide Corporation Information

7.6.2 MaxWell Biosciences Antibacterial Active Peptide Product Portfolio

7.6.3 MaxWell Biosciences Antibacterial Active Peptide Production, Value, Price and Gross Margin (2018-2023)

7.6.4 MaxWell Biosciences Main Business and Markets Served

7.6.5 MaxWell Biosciences Recent Developments/Updates

7.7 ContraFect Corporation

7.7.1 ContraFect Corporation Antibacterial Active Peptide Corporation Information

7.7.2 ContraFect Corporation Antibacterial Active Peptide Product Portfolio

7.7.3 ContraFect Corporation Antibacterial Active Peptide Production, Value, Price and Gross Margin (2018-2023)

7.7.4 ContraFect Corporation Main Business and Markets Served

7.7.5 ContraFect Corporation Recent Developments/Updates

7.8 Lytica Therapeutics , Inc.

7.8.1 Lytica Therapeutics , Inc. Antibacterial Active Peptide Corporation Information

7.8.2 Lytica Therapeutics , Inc. Antibacterial Active Peptide Product Portfolio

7.8.3 Lytica Therapeutics , Inc. Antibacterial Active Peptide Production, Value, Price and Gross Margin (2018-2023)

7.8.4 Lytica Therapeutics , Inc. Main Business and Markets Served

7.7.5 Lytica Therapeutics , Inc. Recent Developments/Updates

7.9 Amprologix

7.9.1 Amprologix Antibacterial Active Peptide Corporation Information

7.9.2 Amprologix Antibacterial Active Peptide Product Portfolio

7.9.3 Amprologix Antibacterial Active Peptide Production, Value, Price and Gross Margin (2018-2023)

7.9.4 Amprologix Main Business and Markets Served

7.9.5 Amprologix Recent Developments/Updates

7.10 Ingenza

7.10.1 Ingenza Antibacterial Active Peptide Corporation Information

7.10.2 Ingenza Antibacterial Active Peptide Product Portfolio

7.10.3 Ingenza Antibacterial Active Peptide Production, Value, Price and Gross Margin (2018-2023)

7.10.4 Ingenza Main Business and Markets Served

7.10.5 Ingenza Recent Developments/Updates

7.11 ReAlta Life Sciences

7.11.1 ReAlta Life Sciences Antibacterial Active Peptide Corporation Information

7.11.2 ReAlta Life Sciences Antibacterial Active Peptide Product Portfolio

7.11.3 ReAlta Life Sciences Antibacterial Active Peptide Production, Value, Price and Gross Margin (2018-2023)

7.11.4 ReAlta Life Sciences Main Business and Markets Served

7.11.5 ReAlta Life Sciences Recent Developments/Updates

7.12 Celdara Medical

7.12.1 Celdara Medical Antibacterial Active Peptide Corporation Information

7.12.2 Celdara Medical Antibacterial Active Peptide Product Portfolio

7.12.3 Celdara Medical Antibacterial Active Peptide Production, Value, Price and Gross Margin (2018-2023)

7.12.4 Celdara Medical Main Business and Markets Served

7.12.5 Celdara Medical Recent Developments/Updates

7.13 Numaferm

7.13.1 Numaferm Antibacterial Active Peptide Corporation Information

7.13.2 Numaferm Antibacterial Active Peptide Product Portfolio

7.13.3 Numaferm Antibacterial Active Peptide Production, Value, Price and Gross Margin (2018-2023)

7.13.4 Numaferm Main Business and Markets Served

7.13.5 Numaferm Recent Developments/Updates

7.14 ALLVIVO VASCULAR, INC.

7.14.1 ALLVIVO VASCULAR, INC. Antibacterial Active Peptide Corporation Information

7.14.2 ALLVIVO VASCULAR, INC. Antibacterial Active Peptide Product Portfolio

7.14.3 ALLVIVO VASCULAR, INC. Antibacterial Active Peptide Production, Value, Price and Gross Margin (2018-2023)

7.14.4 ALLVIVO VASCULAR, INC. Main Business and Markets Served

7.14.5 ALLVIVO VASCULAR, INC. Recent Developments/Updates

7.15 Matrubials

7.15.1 Matrubials Antibacterial Active Peptide Corporation Information

7.15.2 Matrubials Antibacterial Active Peptide Product Portfolio

7.15.3 Matrubials Antibacterial Active Peptide Production, Value, Price and Gross Margin (2018-2023)

7.15.4 Matrubials Main Business and Markets Served

7.15.5 Matrubials Recent Developments/Updates

8.1 Antibacterial Active Peptide Industry Chain Analysis

8.2 Antibacterial Active Peptide Key Raw Materials

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.3 Antibacterial Active Peptide Production Mode & Process

8.4 Antibacterial Active Peptide Sales and Marketing

8.4.1 Antibacterial Active Peptide Sales Channels

8.4.2 Antibacterial Active Peptide Distributors

8.5 Antibacterial Active Peptide Customers

9.1 Antibacterial Active Peptide Industry Trends

9.2 Antibacterial Active Peptide Market Drivers

9.3 Antibacterial Active Peptide Market Challenges

9.4 Antibacterial Active Peptide Market Restraints

11.1 Methodology/Research Approach

11.1.1 Research Programs/Design

11.1.2 Market Size Estimation

11.1.3 Market Breakdown and Data Triangulation

11.2 Data Source

11.2.1 Secondary Sources

11.2.2 Primary Sources

11.3 Author List

11.4 Disclaimer

List of Tables

    Table 1. Global Antibacterial Active Peptide Market Value by Type, (US$ Million) & (2022 VS 2029)

    Table 2. Global Antibacterial Active Peptide Market Value by Application, (US$ Million) & (2022 VS 2029)

    Table 3. Global Antibacterial Active Peptide Production Capacity (Tons) by Manufacturers in 2022

    Table 4. Global Antibacterial Active Peptide Production by Manufacturers (2018-2023) & (Tons)

    Table 5. Global Antibacterial Active Peptide Production Market Share by Manufacturers (2018-2023)

    Table 6. Global Antibacterial Active Peptide Production Value by Manufacturers (2018-2023) & (US$ Million)

    Table 7. Global Antibacterial Active Peptide Production Value Share by Manufacturers (2018-2023)

    Table 8. Global Antibacterial Active Peptide Industry Ranking 2021 VS 2022 VS 2023

    Table 9. Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Antibacterial Active Peptide as of 2022)

    Table 10. Global Market Antibacterial Active Peptide Average Price by Manufacturers (US$/Ton) & (2018-2023)

    Table 11. Manufacturers Antibacterial Active Peptide Production Sites and Area Served

    Table 12. Manufacturers Antibacterial Active Peptide Product Types

    Table 13. Global Antibacterial Active Peptide Manufacturers Market Concentration Ratio (CR5 and HHI)

    Table 14. Mergers & Acquisitions, Expansion

    Table 15. Global Antibacterial Active Peptide Production Value by Region: 2018 VS 2022 VS 2029 (US$ Million)

    Table 16. Global Antibacterial Active Peptide Production Value (US$ Million) by Region (2018-2023)

    Table 17. Global Antibacterial Active Peptide Production Value Market Share by Region (2018-2023)

    Table 18. Global Antibacterial Active Peptide Production Value (US$ Million) Forecast by Region (2024-2029)

    Table 19. Global Antibacterial Active Peptide Production Value Market Share Forecast by Region (2024-2029)

    Table 20. Global Antibacterial Active Peptide Production Comparison by Region: 2018 VS 2022 VS 2029 (Tons)

    Table 21. Global Antibacterial Active Peptide Production (Tons) by Region (2018-2023)

    Table 22. Global Antibacterial Active Peptide Production Market Share by Region (2018-2023)

    Table 23. Global Antibacterial Active Peptide Production (Tons) Forecast by Region (2024-2029)

    Table 24. Global Antibacterial Active Peptide Production Market Share Forecast by Region (2024-2029)

    Table 25. Global Antibacterial Active Peptide Market Average Price (US$/Ton) by Region (2018-2023)

    Table 26. Global Antibacterial Active Peptide Market Average Price (US$/Ton) by Region (2024-2029)

    Table 27. Global Antibacterial Active Peptide Consumption Growth Rate by Region: 2018 VS 2022 VS 2029 (Tons)

    Table 28. Global Antibacterial Active Peptide Consumption by Region (2018-2023) & (Tons)

    Table 29. Global Antibacterial Active Peptide Consumption Market Share by Region (2018-2023)

    Table 30. Global Antibacterial Active Peptide Forecasted Consumption by Region (2024-2029) & (Tons)

    Table 31. Global Antibacterial Active Peptide Forecasted Consumption Market Share by Region (2018-2023)

    Table 32. North America Antibacterial Active Peptide Consumption Growth Rate by Country: 2018 VS 2022 VS 2029 (Tons)

    Table 33. North America Antibacterial Active Peptide Consumption by Country (2018-2023) & (Tons)

    Table 34. North America Antibacterial Active Peptide Consumption by Country (2024-2029) & (Tons)

    Table 35. Europe Antibacterial Active Peptide Consumption Growth Rate by Country: 2018 VS 2022 VS 2029 (Tons)

    Table 36. Europe Antibacterial Active Peptide Consumption by Country (2018-2023) & (Tons)

    Table 37. Europe Antibacterial Active Peptide Consumption by Country (2024-2029) & (Tons)

    Table 38. Asia Pacific Antibacterial Active Peptide Consumption Growth Rate by Region: 2018 VS 2022 VS 2029 (Tons)

    Table 39. Asia Pacific Antibacterial Active Peptide Consumption by Region (2018-2023) & (Tons)

    Table 40. Asia Pacific Antibacterial Active Peptide Consumption by Region (2024-2029) & (Tons)

    Table 41. Latin America, Middle East & Africa Antibacterial Active Peptide Consumption Growth Rate by Country: 2018 VS 2022 VS 2029 (Tons)

    Table 42. Latin America, Middle East & Africa Antibacterial Active Peptide Consumption by Country (2018-2023) & (Tons)

    Table 43. Latin America, Middle East & Africa Antibacterial Active Peptide Consumption by Country (2024-2029) & (Tons)

    Table 44. Global Antibacterial Active Peptide Production (Tons) by Type (2018-2023)

    Table 45. Global Antibacterial Active Peptide Production (Tons) by Type (2024-2029)

    Table 46. Global Antibacterial Active Peptide Production Market Share by Type (2018-2023)

    Table 47. Global Antibacterial Active Peptide Production Market Share by Type (2024-2029)

    Table 48. Global Antibacterial Active Peptide Production Value (US$ Million) by Type (2018-2023)

    Table 49. Global Antibacterial Active Peptide Production Value (US$ Million) by Type (2024-2029)

    Table 50. Global Antibacterial Active Peptide Production Value Share by Type (2018-2023)

    Table 51. Global Antibacterial Active Peptide Production Value Share by Type (2024-2029)

    Table 52. Global Antibacterial Active Peptide Price (US$/Ton) by Type (2018-2023)

    Table 53. Global Antibacterial Active Peptide Price (US$/Ton) by Type (2024-2029)

    Table 54. Global Antibacterial Active Peptide Production (Tons) by Application (2018-2023)

    Table 55. Global Antibacterial Active Peptide Production (Tons) by Application (2024-2029)

    Table 56. Global Antibacterial Active Peptide Production Market Share by Application (2018-2023)

    Table 57. Global Antibacterial Active Peptide Production Market Share by Application (2024-2029)

    Table 58. Global Antibacterial Active Peptide Production Value (US$ Million) by Application (2018-2023)

    Table 59. Global Antibacterial Active Peptide Production Value (US$ Million) by Application (2024-2029)

    Table 60. Global Antibacterial Active Peptide Production Value Share by Application (2018-2023)

    Table 61. Global Antibacterial Active Peptide Production Value Share by Application (2024-2029)

    Table 62. Global Antibacterial Active Peptide Price (US$/Ton) by Application (2018-2023)

    Table 63. Global Antibacterial Active Peptide Price (US$/Ton) by Application (2024-2029)

    Table 64. Lytix Biopharma AS Antibacterial Active Peptide Corporation Information

    Table 65. Lytix Biopharma AS Specification and Application

    Table 66. Lytix Biopharma AS Antibacterial Active Peptide Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2018-2023)

    Table 67. Lytix Biopharma AS Main Business and Markets Served

    Table 68. Lytix Biopharma AS Recent Developments/Updates

    Table 69. Genscript Antibacterial Active Peptide Corporation Information

    Table 70. Genscript Specification and Application

    Table 71. Genscript Antibacterial Active Peptide Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2018-2023)

    Table 72. Genscript Main Business and Markets Served

    Table 73. Genscript Recent Developments/Updates

    Table 74. Biosynth Carbosynth Antibacterial Active Peptide Corporation Information

    Table 75. Biosynth Carbosynth Specification and Application

    Table 76. Biosynth Carbosynth Antibacterial Active Peptide Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2018-2023)

    Table 77. Biosynth Carbosynth Main Business and Markets Served

    Table 78. Biosynth Carbosynth Recent Developments/Updates

    Table 79. CPC Scientific Antibacterial Active Peptide Corporation Information

    Table 80. CPC Scientific Specification and Application

    Table 81. CPC Scientific Antibacterial Active Peptide Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2018-2023)

    Table 82. CPC Scientific Main Business and Markets Served

    Table 83. CPC Scientific Recent Developments/Updates

    Table 84. Peptilogics, Inc. Antibacterial Active Peptide Corporation Information

    Table 85. Peptilogics, Inc. Specification and Application

    Table 86. Peptilogics, Inc. Antibacterial Active Peptide Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2018-2023)

    Table 87. Peptilogics, Inc. Main Business and Markets Served

    Table 88. Peptilogics, Inc. Recent Developments/Updates

    Table 89. MaxWell Biosciences Antibacterial Active Peptide Corporation Information

    Table 90. MaxWell Biosciences Specification and Application

    Table 91. MaxWell Biosciences Antibacterial Active Peptide Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2018-2023)

    Table 92. MaxWell Biosciences Main Business and Markets Served

    Table 93. MaxWell Biosciences Recent Developments/Updates

    Table 94. ContraFect Corporation Antibacterial Active Peptide Corporation Information

    Table 95. ContraFect Corporation Specification and Application

    Table 96. ContraFect Corporation Antibacterial Active Peptide Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2018-2023)

    Table 97. ContraFect Corporation Main Business and Markets Served

    Table 98. ContraFect Corporation Recent Developments/Updates

    Table 99. Lytica Therapeutics , Inc. Antibacterial Active Peptide Corporation Information

    Table 100. Lytica Therapeutics , Inc. Specification and Application

    Table 101. Lytica Therapeutics , Inc. Antibacterial Active Peptide Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2018-2023)

    Table 102. Lytica Therapeutics , Inc. Main Business and Markets Served

    Table 103. Lytica Therapeutics , Inc. Recent Developments/Updates

    Table 104. Amprologix Antibacterial Active Peptide Corporation Information

    Table 105. Amprologix Specification and Application

    Table 106. Amprologix Antibacterial Active Peptide Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2018-2023)

    Table 107. Amprologix Main Business and Markets Served

    Table 108. Amprologix Recent Developments/Updates

    Table 109. Ingenza Antibacterial Active Peptide Corporation Information

    Table 110. Ingenza Specification and Application

    Table 111. Ingenza Antibacterial Active Peptide Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2018-2023)

    Table 112. Ingenza Main Business and Markets Served

    Table 113. Ingenza Recent Developments/Updates

    Table 114. ReAlta Life Sciences Antibacterial Active Peptide Corporation Information

    Table 115. ReAlta Life Sciences Specification and Application

    Table 116. ReAlta Life Sciences Antibacterial Active Peptide Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2018-2023)

    Table 117. ReAlta Life Sciences Main Business and Markets Served

    Table 118. ReAlta Life Sciences Recent Developments/Updates

    Table 119. Celdara Medical Antibacterial Active Peptide Corporation Information

    Table 120. Celdara Medical Specification and Application

    Table 121. Celdara Medical Antibacterial Active Peptide Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2018-2023)

    Table 122. Celdara Medical Main Business and Markets Served

    Table 123. Celdara Medical Recent Developments/Updates

    Table 124. Numaferm Antibacterial Active Peptide Corporation Information

    Table 125. Numaferm Specification and Application

    Table 126. Numaferm Antibacterial Active Peptide Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2018-2023)

    Table 127. Numaferm Main Business and Markets Served

    Table 128. Numaferm Recent Developments/Updates

    Table 129. ALLVIVO VASCULAR, INC. Antibacterial Active Peptide Corporation Information

    Table 130. ALLVIVO VASCULAR, INC. Specification and Application

    Table 131. ALLVIVO VASCULAR, INC. Antibacterial Active Peptide Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2018-2023)

    Table 132. ALLVIVO VASCULAR, INC. Main Business and Markets Served

    Table 133. ALLVIVO VASCULAR, INC. Recent Developments/Updates

    Table 134. ALLVIVO VASCULAR, INC. Antibacterial Active Peptide Corporation Information

    Table 135. Matrubials Specification and Application

    Table 136. Matrubials Antibacterial Active Peptide Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2018-2023)

    Table 137. Matrubials Main Business and Markets Served

    Table 138. Matrubials Recent Developments/Updates

    Table 139. Key Raw Materials Lists

    Table 140. Raw Materials Key Suppliers Lists

    Table 141. Antibacterial Active Peptide Distributors List

    Table 142. Antibacterial Active Peptide Customers List

    Table 143. Antibacterial Active Peptide Market Trends

    Table 144. Antibacterial Active Peptide Market Drivers

    Table 145. Antibacterial Active Peptide Market Challenges

    Table 146. Antibacterial Active Peptide Market Restraints

    Table 147. Research Programs/Design for This Report

    Table 148. Key Data Information from Secondary Sources

    Table 149. Key Data Information from Primary Sources

List of Figures

    Figure 1. Product Picture of Antibacterial Active Peptide

    Figure 2. Global Antibacterial Active Peptide Market Value by Type, (US$ Million) & (2022 VS 2029)

    Figure 3. Global Antibacterial Active Peptide Market Share by Type: 2022 VS 2029

    Figure 4. Microbial Antimicrobial Peptides Product Picture

    Figure 5. Plant Antimicrobial Peptides Product Picture

    Figure 6. Animal Antimicrobial Peptides Product Picture

    Figure 7. Others Product Picture

    Figure 8. Global Antibacterial Active Peptide Market Value by Application, (US$ Million) & (2022 VS 2029)

    Figure 9. Global Antibacterial Active Peptide Market Share by Application: 2022 VS 2029

    Figure 10. Food

    Figure 11. Medical

    Figure 12. Animal Food

    Figure 13. Others

    Figure 14. Global Antibacterial Active Peptide Production Value (US$ Million), 2018 VS 2022 VS 2029

    Figure 15. Global Antibacterial Active Peptide Production Value (US$ Million) & (2018-2029)

    Figure 16. Global Antibacterial Active Peptide Production Capacity (Tons) & (2018-2029)

    Figure 17. Global Antibacterial Active Peptide Production (Tons) & (2018-2029)

    Figure 18. Global Antibacterial Active Peptide Average Price (US$/Ton) & (2018-2029)

    Figure 19. Antibacterial Active Peptide Report Years Considered

    Figure 20. Antibacterial Active Peptide Production Share by Manufacturers in 2022

    Figure 21. Antibacterial Active Peptide Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022

    Figure 22. The Global 5 and 10 Largest Players: Market Share by Antibacterial Active Peptide Revenue in 2022

    Figure 23. Global Antibacterial Active Peptide Production Value by Region: 2018 VS 2022 VS 2029 (US$ Million)

    Figure 24. Global Antibacterial Active Peptide Production Value Market Share by Region: 2018 VS 2022 VS 2029

    Figure 25. Global Antibacterial Active Peptide Production Comparison by Region: 2018 VS 2022 VS 2029 (Tons)

    Figure 26. Global Antibacterial Active Peptide Production Market Share by Region: 2018 VS 2022 VS 2029

    Figure 27. North America Antibacterial Active Peptide Production Value (US$ Million) Growth Rate (2018-2029)

    Figure 28. Europe Antibacterial Active Peptide Production Value (US$ Million) Growth Rate (2018-2029)

    Figure 29. China Antibacterial Active Peptide Production Value (US$ Million) Growth Rate (2018-2029)

    Figure 30. Japan Antibacterial Active Peptide Production Value (US$ Million) Growth Rate (2018-2029)

    Figure 31. Global Antibacterial Active Peptide Consumption by Region: 2018 VS 2022 VS 2029 (Tons)

    Figure 32. Global Antibacterial Active Peptide Consumption Market Share by Region: 2018 VS 2022 VS 2029

    Figure 33. North America Antibacterial Active Peptide Consumption and Growth Rate (2018-2023) & (Tons)

    Figure 34. North America Antibacterial Active Peptide Consumption Market Share by Country (2018-2029)

    Figure 35. Canada Antibacterial Active Peptide Consumption and Growth Rate (2018-2023) & (Tons)

    Figure 36. U.S. Antibacterial Active Peptide Consumption and Growth Rate (2018-2023) & (Tons)

    Figure 37. Europe Antibacterial Active Peptide Consumption and Growth Rate (2018-2023) & (Tons)

    Figure 38. Europe Antibacterial Active Peptide Consumption Market Share by Country (2018-2029)

    Figure 39. Germany Antibacterial Active Peptide Consumption and Growth Rate (2018-2023) & (Tons)

    Figure 40. France Antibacterial Active Peptide Consumption and Growth Rate (2018-2023) & (Tons)

    Figure 41. U.K. Antibacterial Active Peptide Consumption and Growth Rate (2018-2023) & (Tons)

    Figure 42. Italy Antibacterial Active Peptide Consumption and Growth Rate (2018-2023) & (Tons)

    Figure 43. Russia Antibacterial Active Peptide Consumption and Growth Rate (2018-2023) & (Tons)

    Figure 44. Asia Pacific Antibacterial Active Peptide Consumption and Growth Rate (2018-2023) & (Tons)

    Figure 45. Asia Pacific Antibacterial Active Peptide Consumption Market Share by Regions (2018-2029)

    Figure 46. China Antibacterial Active Peptide Consumption and Growth Rate (2018-2023) & (Tons)

    Figure 47. Japan Antibacterial Active Peptide Consumption and Growth Rate (2018-2023) & (Tons)

    Figure 48. South Korea Antibacterial Active Peptide Consumption and Growth Rate (2018-2023) & (Tons)

    Figure 49. China Taiwan Antibacterial Active Peptide Consumption and Growth Rate (2018-2023) & (Tons)

    Figure 50. Southeast Asia Antibacterial Active Peptide Consumption and Growth Rate (2018-2023) & (Tons)

    Figure 51. India Antibacterial Active Peptide Consumption and Growth Rate (2018-2023) & (Tons)

    Figure 52. Latin America, Middle East & Africa Antibacterial Active Peptide Consumption and Growth Rate (2018-2023) & (Tons)

    Figure 53. Latin America, Middle East & Africa Antibacterial Active Peptide Consumption Market Share by Country (2018-2029)

    Figure 54. Mexico Antibacterial Active Peptide Consumption and Growth Rate (2018-2023) & (Tons)

    Figure 55. Brazil Antibacterial Active Peptide Consumption and Growth Rate (2018-2023) & (Tons)

    Figure 56. Turkey Antibacterial Active Peptide Consumption and Growth Rate (2018-2023) & (Tons)

    Figure 57. GCC Countries Antibacterial Active Peptide Consumption and Growth Rate (2018-2023) & (Tons)

    Figure 58. Global Production Market Share of Antibacterial Active Peptide by Type (2018-2029)

    Figure 59. Global Production Value Market Share of Antibacterial Active Peptide by Type (2018-2029)

    Figure 60. Global Antibacterial Active Peptide Price (US$/Ton) by Type (2018-2029)

    Figure 61. Global Production Market Share of Antibacterial Active Peptide by Application (2018-2029)

    Figure 62. Global Production Value Market Share of Antibacterial Active Peptide by Application (2018-2029)

    Figure 63. Global Antibacterial Active Peptide Price (US$/Ton) by Application (2018-2029)

    Figure 64. Antibacterial Active Peptide Value Chain

    Figure 65. Antibacterial Active Peptide Production Process

    Figure 66. Channels of Distribution (Direct Vs Distribution)

    Figure 67. Distributors Profiles

    Figure 68. Bottom-up and Top-down Approaches for This Report

    Figure 69. Data Triangulation